Topics

High-grade gliomas | Treatment | Immunotherapy | Overview

Home > Publications > Topics > High-grade gliomas > Treatment > Immunotherapy > Overview

Palavani LB, Mitre LP, Camerotte R, Nogueira BV, Canto GL, Chen HC, Pacheco-Barrios N, Ferreira MY, Batista S, Andreão FF, Polverini AD, Montenegro TS, Paiva W, Ferreira C, Bertani R, D'Amico RS.
Advancements and challenges: immunotherapy therapy in high-grade glioma - a meta-analysis of randomized clinical trials.
J Neurooncol. 2024 Sep 4. doi: 10.1007/s11060-024-04813-0. PMID: 39230804. Review˰ ˍ

Karbhari N, Frechette KM, Burns TC, Parney IF, Campian JL, Breen WG, Sener UT, Lehrer EJ.
Immunotherapy for High-Grade Gliomas.
Cancers (Basel). 2025 May 31;17(11):1849. doi: 10.3390/cancers17111849. PMID: 40507329. Review. ˍ

Hsueh B, Steuart SJ, Odukoya AO, Prager BC, Kim YJ, Hill CM, Choi BD, Dunn GP.
Immunotherapy and targeted therapy for high grade gliomas: current and future directions.
J Neurooncol. 2025 Dec 9;176(1):112. doi: 10.1007/s11060-025-05315-3. PMID: 41366148. Review˰ ˍ

Ramsoomair CK, Daftari M, Benchouia R, Estevez-Ordonez D, Aka A, Himic V, Aramburu-Berckemeyer M, Kreatsoulas D, Govindarajan V, Chandar JS, Ivan ME, Komotar RJ, Shah A.
Locoregional delivery of CAR T cells in high-grade gliomas: a systematic analysis of safety, efficacy, and emerging biomarkers of response.
J Immunother Cancer. 2026 Mar 27;14(3):e014450. doi: 10.1136/jitc-2025-014450. PMID: 41895715. ˍ